Nigeria Launches Probe into Chinese Drugs
Allegedly
Nigeria Launches Probe into Chinese Drugs
Allegedly Containing Human Flesh, Fetus Remains
< >
Left knows quite a bit about abortion 'material'
Nigeria’s top intelligence agency warned that Chinese drug makers might be smuggling medicine “containing human remains from fetuses, infants, and flesh” into the country, prompting lawmakers to launch an investigation on Wednesday, the local Guardian newspaper reported.
The Guardian quoted a recent memo from the African country’s National Intelligence Agency (NIA) as cautioning Nigerians:
The South Korean Customs Service on September 30, 2018, revealed that it had seized 2,751 Chinese drugs/capsules, containing human remains from fetuses, infants and flesh imported into the country by some Chinese nationals. It stressed that the making of the human remain drugs and consuming them are crimes against humanity, which can also lead to serious health challenges.
Nigeria’s Vanguard newspaper learned that the NIA also learned from South Korea that the Chinese capsules also contained “18.7 billion viruses, including hepatitis B.”
Ads by Revcontent
33 Embarrassing Photos You Must See
Routinejournal
Add Your Name to the Official Petition to Force Congress to Stop the Caravan!
Make America Great Again
Indianapolis Drivers With No Tickets Since Oct 2015 Stunned By Policy
Discount Drivers
On Wednesday, Nigerian lawmakers adopted a measure ordering authorities to identify and arrest the persons behind the alleged gruesome trade.
Officials from the Nigerian committees on health services; women affairs and social development; information; national orientation; and ethics and values are expected to work on the investigation with the Nigeria Customs Service (NIS), the National Agency for Food and Drug Administration and Control (NAFDAC) and the NIA.
Nigerian lawmakers approved the motion to investigate, sponsored by Johnson Agbonayinma from Edo, by unanimous consent.
Agbonayinma described the allegation as a crime against humanity, “which can also lead to serious health challenges,” the Cable reported.
“If immediate measures are not taken to stem the influx of these drugs and the illegal importers, it will continue to endanger the lives of citizens,” he added.
The Guardian acknowledges:
This is not the first time China has been in the eye of the storm over its exports. In 2007, Panamanian Eduardo Arias discovered that toothpaste sold in his country was labeled as containing Diethylene glycol (DEG), the same ingredient that had tainted cough syrup and killed 138 Panamanians in 2006. Panamanian officials discovered the toothpaste came from China and initiated a global response.
Authorities have also accused China of making drugs from babies in the past, Vanguard noted.
“In 2011, Chinese officials launched investigations into the production of drugs made from dead fetuses,” the newspaper noted on October 19. “The capsules were disguised as stamina boosters and some people believe them to be a panacea for disease.”
China lacks clear standards and guidelines for drug manufacturers, Yazan Saleh, associate analyst at Decision Resources Group in Canda, told the Guardian.
“In recent years, more regulations have been put in place but the question of enforcement of these remains a challenge,” he declared.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...
Continue Reading
What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...
Continue Reading
Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...
Continue Reading
DERMALOG Rides High with PAD Success Germany-based DERMALOG just gave biometric crooks a run for their money. In a testament to gutsy tech work, they've hit a homerun with the latest independent security evaluations. They’ve managed to spot and shut down all 1,500 tried and tested spoofs in presentation attacks—think photos, videos, and phony fingerprints. That’s no...
Continue Reading
ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...
Continue Reading
Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...
Continue Reading
Leading the Pack with AI-Powered Security In the world of cybersecurity, where every day feels like a battlefield, Arctic Wolf has clawed its way to the top spot in the Q4 2026 QKS SPARK Matrix™ for AI SOC Automation. This recognition doesn't just highlight their prowess in handling security operations; it underscores their relentless commitment to infusing AI...
Continue Reading
Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...
Continue Reading
RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...
Continue Reading
CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Challenges Facing U.S. Health Insurers Recent analyses reveal that U.S. health insurers are grappling with a combination of regulatory pressures and financial uncertainties. These challenges are expected to significantly impact their operations and strategies in the coming years. The changing landscape has raised concerns not only among the insurers...
Continue Reading
XRP's Recent Performance and Future Projections XRP (CRYPTO: XRP) recently experienced a 10% drop, dipping below $3. While this has raised concerns among some investors, many seasoned traders remain optimistic about the coin’s potential for a significant rally as we head into the final quarter of the year. Strong market fundamentals suggest XRP could still showcase a...
Continue Reading
Kronos Worldwide, Inc. Prepares for Q2 Earnings Announcement Kronos Worldwide, Inc. is gearing up to share its financial performance for the second quarter of 2025. This announcement, crucial for investors and stakeholders, will come after the market closes on a Wednesday in early August. This timing allows investors to digest the financial results before the next trading...
Continue Reading
Shell plc's Share Repurchase Initiative Shell plc has taken a significant step in its financial strategy with a recent share repurchase program, allowing for the cancellation of a substantial number of shares. This action reflects the company's commitment to enhancing shareholder value by actively managing its capital. Details of the Share Purchases On a notable day, the...
Continue Reading
Class Action Lawsuit Against Baxter International Begins Baxter International, Inc. has recently come under scrutiny with the announcement of a class action lawsuit filed in the United States District Court. This legal action represents buyers of Baxter's stock from a specified period. The lawsuit alleges serious claims regarding the company’s practices and the...
Continue Reading